Adicet Bio stock soars 13% on FDA fast track status for ADI-001 to treat blood cancer | Seeking Alpha

Retrieved on: 2022-04-19 16:29:37

Tags for this article:

Click the tags to see associated articles and topics

Adicet Bio stock soars 13% on FDA fast track status for ADI-001 to treat blood cancer | Seeking Alpha. View article details on hiswai:

Excerpt

Adicet Bio stock soars 13% on FDA fast track status for ADI-001 to treat ... begins in the lymphatic system, which is part of the immune system.

Article found on: seekingalpha.com